medicinal products articles & resources on Made-in-China.com

Bischof + Klein Takes Certification That It Meets High Hygiene Requirements Food Products

Dec 17, 2014

Manufacturers of flexible plastic, laminate packaging and technical films Bischof + Klein have been given a certification that it meets high hygiene requirements for the packaging of food products. This certification was confirmed by ...

Tags: flexible plastic, laminate packaging, Agriculture

PCI Has Acquired Pharmaceutical Services Provider Biotec

Sep 23, 2014

Packaging services provider Packaging Coordinators (PCI) has acquired pharmaceutical services provider Biotec for an undisclosed amount. Headquartered in Wales, Biotec is a provider of clinical trials and temperature controlled ...

Tags: PCI, Biotec, Packaging

GlaxoSmithKline Says It Received a Positive Opinion in Europe for Albiglutide

Feb 10, 2014

LONDON, Jan. 26 (UPI) -- GlaxoSmithKline says it received a positive opinion in Europe for albiglutide, under the brand name Eperzan, for treatment of type 2 diabetes. GSK officials said the Committee for Medicinal Products for Human Use ...

Tags: Albiglutide, Glaxosmithkline, FDA

Teva and Active Biotech Have Announced That Both Companies Remain

Feb 10, 2014

Teva Pharmaceutical Industries and Active Biotech have announced that both companies remain committed to the Nerventra(laquinimod)clinical development program for multiple sclerosis(MS)following the announcement of a negative opinion for ...

Tags: Medicine, clinical studies, Nerventra

CHMP Has Issued a Positive Opinion for The Use of Novartis' Xolair as an Add-on Therapy

Feb 10, 2014

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Novartis’ Xolair (omalizumab) as an add-on therapy for the treatment of chronic spontaneous ...

Tags: Chmp, Chronic Spontaneous Urticaria

Their Joint Aim Is to Identify New Therapeutic Targets in 'Triple Negative' Breast Cancers

Feb 7, 2014

Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have ...

Tags: triple negative, Curie-Cancer, TTK/MPS1, Institut Curie and Servier

European Commission Approve Roche's MabThera 1400mg Solution for SC Injection

Feb 7, 2014

The EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for the treatment of patients with common forms ...

Tags: CHMP, NHL, SC, CD20

CHMP Adopted a Positive Opinion on FINOX Biotech's MAA for BEMFOLA

Feb 7, 2014

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on FINOX Biotech's marketing authorisation application (MAA) for BEMFOLA (follitropin alfa solution for injection in ...

Tags: CHMP, EMA, BEMFOLA, IVF

Nebulizers Aren't Providing People with Asthma a Full Dose of Medication

Dec 27, 2013

Nebulizers -- devices that transform liquid asthma medications into an easy-to-inhale mist -- aren't providing people with asthma a full dose of medication, according to a small new study. Researchers found that less than 20 percent of ...

Tags: Nebulizers, liquid asthma medications, kids health

European Commission Would Amend The Erbitux® (Cetuximab) Product Information

Dec 23, 2013

Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the Type II variation to amend the Erbitux® (cetuximab) product information, updating the indication for Erbitux to the ...

Tags: Health, Medicine

FDA Has Approved Sovaldi 400mg Tablets

Dec 10, 2013

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...

Tags: Gilead Sciences, Chronic Hepatitis

Sanofi Has Released Results of a 24-Week Phase Iiib Clinical Trial

Dec 9, 2013

Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered to patients either before breakfast or the ...

Tags: Diabetes Drug, Medicine

Colored Glass Related to American Culture and Design

Dec 3, 2013

Soda lime glass is basically colorless. Metals and oxides can be added to glass to change its color during the glass blowing, molding or machine production process. The following additives make the distinctive colors: •Red glass: ...

Tags: colored glass, decoration

EMA Has Fully Validated and Granted Accelerated Assessment

Nov 28, 2013

The European Medicines Agency (EMA) has fully validated and granted accelerated assessment to Boehringer Ingelheim's application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor. ...

Tags: Health, Medicine

Insulin Pump Therapy for Diabetics Get Easier Due to Novo Nordisk and Roche Diabetes

Nov 26, 2013

Denmark-based Novo Nordisk has announced that the European Medicines Agency (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of the NovoRapid PumpCart in Europe. NovoRapid PumpCart is a 1.6ml ...

Tags: Health, Medicine

medicinal products

Related Products